Literature DB >> 21092304

Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON).

Levente Kriston1, Alessa von Wolff, Lars Hölzel.   

Abstract

BACKGROUND: Chronic depressions represent a substantial part of depressive disorders and are associated with severe consequences. Several studies were performed addressing the effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depressions. Yet, a systematic review comparing the effectiveness of multiple treatment options and considering all subtypes of chronic depressions is still missing. METHODS/
DESIGN: Aim of this project is to summarize empirical evidence on efficacy and effectiveness of treatments for chronic depression by means of a systematic review. The primary objectives of the study are to examine, which interventions are effective; to examine, if any differences in effectiveness between active treatment options exist; and to find possible treatment effect modifiers. Psychotherapeutic, pharmacological, and combined treatments will be considered as experimental interventions and no treatment, wait-list, psychological/pharmacological placebo, treatment as usual, and other active treatments will be seen as comparators. The population of patients will include adults with chronic major depression, dysthymia, double depression, or recurrent depression without complete remission between episodes. Outcomes of the analyses are depressive symptoms, associated consequences, adverse events, and study discontinuation. Only randomized controlled trials will be considered. DISCUSSION: Given the high prevalence and serious consequences of chronic depression and a considerable amount of existing primary studies addressing the effectiveness of different treatments the present systematic review may be of high relevance. Special attention will be given to the use of current methodological standards. Findings are likely to provide crucial information that may help clinicians to choose the appropriate treatment for chronically depressed patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21092304      PMCID: PMC3002317          DOI: 10.1186/1471-244X-10-95

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  35 in total

1.  Explaining heterogeneity in meta-analysis: a comparison of methods.

Authors:  S G Thompson; S J Sharp
Journal:  Stat Med       Date:  1999-10-30       Impact factor: 2.373

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

4.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials.

Authors:  H C Bucher; G H Guyatt; L E Griffith; S D Walter
Journal:  J Clin Epidemiol       Date:  1997-06       Impact factor: 6.437

5.  Imputing response rates from means and standard deviations in meta-analyses.

Authors:  Toshi A Furukawa; Andrea Cipriani; Corrado Barbui; Paolo Brambilla; Norio Watanabe
Journal:  Int Clin Psychopharmacol       Date:  2005-01       Impact factor: 1.659

6.  Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder.

Authors:  D L Dunner; K B Schmaling; H Hendrickson; J Becker; A Lehman; C Bea
Journal:  Depression       Date:  1996

7.  Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project.

Authors:  W S Gilmer; M H Trivedi; A J Rush; S R Wisniewski; J Luther; R H Howland; D Yohanna; A Khan; J Alpert
Journal:  Acta Psychiatr Scand       Date:  2005-12       Impact factor: 6.392

8.  A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients.

Authors:  John C Markowitz; James H Kocsis; Kathryn L Bleiberg; Paul J Christos; Michael Sacks
Journal:  J Affect Disord       Date:  2005-11-02       Impact factor: 4.839

9.  Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.

Authors:  A V Ravindran; H Anisman; Z Merali; Y Charbonneau; J Telner; R J Bialik; A Wiens; J Ellis; J Griffiths
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

10.  Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.

Authors:  Elisabeth Schramm; Daniel Schneider; Ingo Zobel; Dietrich van Calker; Petra Dykierek; Sabine Kech; Martin Härter; Mathias Berger
Journal:  J Affect Disord       Date:  2007-12-11       Impact factor: 4.839

View more
  7 in total

1.  Stigma Predicts Treatment Preferences and Care Engagement Among Veterans Affairs Primary Care Patients with Depression.

Authors:  Duncan G Campbell; Laura M Bonner; Cory R Bolkan; Andrew B Lanto; Kara Zivin; Thomas J Waltz; Ruth Klap; Lisa V Rubenstein; Edmund F Chaney
Journal:  Ann Behav Med       Date:  2016-08

Review 2.  Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis.

Authors:  Alessa von Wolff; Lars P Hölzel; Annika Westphal; Martin Härter; Levente Kriston
Journal:  BMC Psychiatry       Date:  2012-06-13       Impact factor: 3.630

3.  Efficiency and contribution of strategies for finding randomized controlled trials: a case study from a systematic review on therapeutic interventions of chronic depression.

Authors:  Annika Westphal; Levente Kriston; Lars P Hölzel; Martin Härter; Alessa von Wolff
Journal:  J Public Health Res       Date:  2014-07-01

4.  Side effects of the metacognitive training for depression compared to a cognitive remediation training in patients with depression.

Authors:  Mona Dietrichkeit; Marion Hagemann-Goebel; Yvonne Nestoriuc; Steffen Moritz; Lena Jelinek
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

Review 5.  The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review.

Authors:  Madelon L J M van Hees; Thomas Rotter; Tim Ellermann; Silvia M A A Evers
Journal:  BMC Psychiatry       Date:  2013-01-11       Impact factor: 3.630

6.  Comparison of the Effect of Mindfulness-based Cognitive Therapy Accompanied by Pharmacotherapy With Pharmacotherapy Alone in Treating Dysthymic Patients.

Authors:  Sajedeh Hamidian; Abdollah Omidi; Seyyed Masoud Mousavinasab; Ghasem Naziri
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

Review 7.  Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis.

Authors:  Ramona Meister; Alessa von Wolff; Hannes Mohr; Martin Härter; Yvonne Nestoriuc; Lars Hölzel; Levente Kriston
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.